Lead Exposure and Multiple Sclerosis

Starting soon

Conditions studied: Multiple Sclerosis

In brief

1. To evaluate the effect of lead level on the pathogenesis of multiple sclerosis 2. Measure lead in blood sample of study groups 3. Estimate the expression level of DNA methyltransferase. 4. Evaluate oxidative stress markers, like MDA/8-OHdG 5. Measureδ-aminolevulinic acid 6. Correlate the clinical data of patients with biochemical markers

Key facts

Study ID

NCT07423312

Run by

Assiut University

People needed

140

Starts

2026-12-30

Expected to finish

2029-05-05

Last updated by the study team

2026-02-20

Who can join

Age: 20 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• patients aged20-50 years diagnosed MS patients according to Mc Donald criteria

You may not qualify if…

• other autoimmune disease Chronic renal or liver disease

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.